Status:
NOT_YET_RECRUITING
Blood Biomarkers Based Screening for HPV-driven OPC
Lead Sponsor:
UNICANCER
Conditions:
Head and Neck Squamous Cell Carcinoma
Anal Cancer
Eligibility:
MALE
50+ years
Phase:
NA
Brief Summary
The objective of our study is to demonstrate that it is possible to detect and treat human papilloma virus (HPV)-related oropharyngeal cancers (OPC) early using simple blood tests. The success of this...
Detailed Description
OPC caused by HPV are the most common head and neck cancers and are expected to increase in the future, especially since HPV vaccines are not widely used. Currently, there are no screening strategy av...
Eligibility Criteria
Inclusion
- Aged ≥50 years from the general population
- Man
- No previous history of HPV-driven cancer or head neck cancer
- Willingness to complete follow up visits
Exclusion
- Aged \< 50 years
- Woman
- History of HPV-driven cancer or head and neck cancer
- Psychiatric conditions
- Inability to complete follow up visits
- Severe medical condition (life expectancy \<5 years)
- Previous prophylactic HPV vaccination
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2032
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06528353
Start Date
January 1 2026
End Date
January 1 2032
Last Update
September 19 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.